Powl Brian T.
- SEC CIK
- 0001934232
In the past year, 6 open-market sale filings worth $397.9K and no purchases.
Current role at each company
- KURA Kura Oncology, Inc.Chief Commercial Officeras of Aug 24, 2026
- FATE Fate Therapeutics IncChief Commercial Officeras of Jul 6, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $397.9K
- 6 filings
- Net
- −$397.9K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Powl Brian T. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
KURA Kura Oncology, Inc.
Chief Commercial Officer7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 24, 2026 (view filing)5:30 PM ET | Aug 21 | 3 days | Powl Brian T.Chief Commercial Officer | SSale | −4.34K | $11.89 | −$51.7K | −2.5%169.3K after | 10b5-1 |
| May 22, 2026 (view filing) | May 21 | 1 day | Powl Brian T.Chief Commercial Officer | SSale | −10.0K | $11.00 | −$110.0K | −5.4%173.6K after | 10b5-1 |
| May 20, 2026 (view filing) | May 19 | 1 day | Powl Brian T.Chief Commercial Officer | SSale | −339 | $9.21 | −$3.12K | −0.2%183.6K after | 10b5-1 |
| Jan 27, 2026 (view filing) | Jan 27 | Same day | Powl Brian T.Chief Commercial Officer | SSale | −6.41K | $8.46 | −$54.3K | −3.4%183.3K after | 2 lots |
| Nov 14, 2025 (view filing) | Nov 14 | Same day | Powl Brian T.Chief Commercial Officer | SSale | −8.89K | $11.18 | −$99.4K | −6.0%139.7K after | |
| Sep 29, 2025 (view filing) | Sep 29 | Same day | Powl Brian T.Chief Commercial Officer | SSale | −8.89K | $8.94 | −$79.5K | −8.2%99.7K after | |
| Jan 28, 2025 (view filing) | Jan 28 | Same day | Powl Brian T.Chief Commercial Officer | SSale | −1.58K | $7.87 | −$12.5K | −2.6%59.7K after |
FATE Fate Therapeutics Inc
Chief Commercial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 6, 2023 (view filing) | Jul 5 | 1 day | Powl Brian T.Chief Commercial Officer | SSale | −3.85K | $4.87 | −$18.8K | −8.6%41.1K after |